ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 139 filers reported holding ACCELERON PHARMA INC in Q3 2016. The put-call ratio across all filers is 1.27 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $344,000 | +37.1% | 2,000 | 0.0% | 0.01% | +25.0% |
Q2 2021 | $251,000 | -7.4% | 2,000 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $271,000 | +5.9% | 2,000 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $256,000 | +13.8% | 2,000 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $225,000 | -83.2% | 2,000 | -94.9% | 0.00% | -50.0% |
Q2 2016 | $1,342,000 | +163.1% | 39,500 | +104.4% | 0.01% | +14.3% |
Q1 2016 | $510,000 | -7.6% | 19,325 | +70.6% | 0.01% | 0.0% |
Q4 2015 | $552,000 | +95.7% | 11,325 | 0.0% | 0.01% | +75.0% |
Q3 2015 | $282,000 | -21.2% | 11,325 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $358,000 | -18.8% | 11,325 | -2.2% | 0.00% | -20.0% |
Q1 2015 | $441,000 | -2.2% | 11,575 | 0.0% | 0.01% | 0.0% |
Q4 2014 | $451,000 | +47.9% | 11,575 | +14.9% | 0.01% | +66.7% |
Q3 2014 | $305,000 | -30.0% | 10,075 | -21.4% | 0.00% | -25.0% |
Q2 2014 | $436,000 | -11.7% | 12,825 | -10.5% | 0.00% | -42.9% |
Q1 2014 | $494,000 | +31.4% | 14,325 | +50.8% | 0.01% | +40.0% |
Q4 2013 | $376,000 | – | 9,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |